297 related articles for article (PubMed ID: 20937102)
1. Moving towards supraspinal TRPV1 receptors for chronic pain relief.
Palazzo E; Luongo L; de Novellis V; Berrino L; Rossi F; Maione S
Mol Pain; 2010 Oct; 6():66. PubMed ID: 20937102
[TBL] [Abstract][Full Text] [Related]
2. Role of TRPV1 receptors in descending modulation of pain.
Palazzo E; Rossi F; Maione S
Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659
[TBL] [Abstract][Full Text] [Related]
3. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways.
Starowicz K; Maione S; Cristino L; Palazzo E; Marabese I; Rossi F; de Novellis V; Di Marzo V
J Neurosci; 2007 Dec; 27(50):13739-49. PubMed ID: 18077685
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid type 1 and pain development.
Palazzo E; Luongo L; de Novellis V; Rossi F; Marabese I; Maione S
Curr Opin Pharmacol; 2012 Feb; 12(1):9-17. PubMed ID: 22104468
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.
Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V
J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510
[TBL] [Abstract][Full Text] [Related]
6. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
7. TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.
Louis-Gray K; Tupal S; Premkumar LS
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077412
[TBL] [Abstract][Full Text] [Related]
8. The role of spinal cord vanilloid (TRPV1) receptors in pain modulation.
Spicarová D; Palecek J
Physiol Res; 2008; 57 Suppl 3():S69-S77. PubMed ID: 18481913
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cannabinoid Receptors in the Descending Modulation of Pain.
Palazzo E; Luongo L; Novellis V; Rossi F; Maione S
Pharmaceuticals (Basel); 2010 Aug; 3(8):2661-2673. PubMed ID: 27713370
[TBL] [Abstract][Full Text] [Related]
10. TRPV3 modulates nociceptive signaling through peripheral and supraspinal sites in rats.
McGaraughty S; Chu KL; Xu J; Leys L; Radek RJ; Dart MJ; Gomtsyan A; Schmidt RG; Kym PR; Brederson JD
J Neurophysiol; 2017 Aug; 118(2):904-916. PubMed ID: 28468993
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.
Chakraborty S; Elvezio V; Kaczocha M; Rebecchi M; Puopolo M
J Physiol; 2017 Apr; 595(8):2639-2660. PubMed ID: 28094445
[TBL] [Abstract][Full Text] [Related]
12. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
[TBL] [Abstract][Full Text] [Related]
13. Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
Mohammadi-Farani A; Sahebgharani M; Sepehrizadeh Z; Jaberi E; Ghazi-Khansari M
Brain Res; 2010 Apr; 1328():49-56. PubMed ID: 20211611
[TBL] [Abstract][Full Text] [Related]
14. Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Silva M; Martins D; Charrua A; Piscitelli F; Tavares I; Morgado C; Di Marzo V
Neuropharmacology; 2016 Aug; 107():49-57. PubMed ID: 26965218
[TBL] [Abstract][Full Text] [Related]
15. 17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons.
Xu S; Cheng Y; Keast JR; Osborne PB
Endocrinology; 2008 Nov; 149(11):5540-8. PubMed ID: 18617618
[TBL] [Abstract][Full Text] [Related]
16. Dissecting TRPV1: lessons to be learned?
Grimm C; Aneiros E; de Groot M
Channels (Austin); 2011; 5(3):201-4. PubMed ID: 21654202
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse.
Sikand P; Premkumar LS
J Physiol; 2007 Jun; 581(Pt 2):631-47. PubMed ID: 17363391
[TBL] [Abstract][Full Text] [Related]
18. Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain.
Kim YS; Chu Y; Han L; Li M; Li Z; LaVinka PC; Sun S; Tang Z; Park K; Caterina MJ; Ren K; Dubner R; Wei F; Dong X
Neuron; 2014 Feb; 81(4):873-887. PubMed ID: 24462040
[TBL] [Abstract][Full Text] [Related]
19. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S;
Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956
[TBL] [Abstract][Full Text] [Related]
20. Multisteric TRPV1 nocisensor: a target for analgesics.
Szolcsányi J; Sándor Z
Trends Pharmacol Sci; 2012 Dec; 33(12):646-55. PubMed ID: 23068431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
